Related Experiment Video
Updated: Jul 6, 2026

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
Published on: November 17, 2023
Shifting focus to cancer survivorship in prostate cancer: challenges and opportunities
1Department of Urology, University of Michigan, Ann Arbor, Michigan 48109, USA. scotgilb@umich.edu
Purpose Of Review:
As strides have been achieved in cancer control, issues faced by survivors have become increasingly relevant. Currently, there are more than 10 million cancer survivors living in the US and consequently cancer survivorship has become a major health priority. Approximately 2 million prostate cancer survivors face a host of long-term and late effects following cancer therapy. Although progress has been made in recognizing many of the issues faced by survivors, gaps in comprehensive surveillance and management still exist.
Recent Findings:
In its recent report, From Cancer Patient to Cancer Survivor: Lost in Transition, the Institute of Medicine outlined deficits in the care provided to cancer survivors and proposed several mechanisms to improve the coordination and quality of follow-up care. Measures to achieve these objectives include improving communication between healthcare providers through a survivorship care plan, developing an evidence base to better support surveillance guidelines, and assessing different models of survivorship care.
Summary:
Potential shortcomings in the recognition and management of ongoing issues faced by prostate cancer survivors may impact the overall quality of long-term care in this growing population. Although programs to address these issues have been proposed, they are in the earliest phase of development.
Related Concept Videos
Cancer Survival Analysis
Treatment Resistant Cancers
Treatment Resistent Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Prevention
Some...
